Home > Resources > Whitepapers > Planet Positive Chemicals

Chemical Technology, Chemical Management

Planet Positive Chemicals

September 24, 2022

Planet Positive
Climate action in the global chemical industry is lagging compared to other sectors. As of August 2022, only seventeen industry players had committed to targets in line
with a 1.5 degrees future as part of the Science Based Targets initiative (SBTi).

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

OTHER WHITEPAPERS
news image

Achieving the next frontier of chemicals excellence Digital maturity model to help ease the transition

whitePaper | December 30, 2019

The chemicals industry is going through a transformation. Many existing and emerging trends are shaping the future of the industry, which include increasing competition, a shift in economic power, disruptive innovations in end markets, changes in feedstock, accelerating commoditization, sustainability, digitization, and Industry 4.0. These key developments which are determining the future of chemicals broadly fall into three key themes: ‘Growth and innovation’, ‘Performance and cost optimization’, and ‘Sustainability and circular economy’.

Read More
news image

Chemical Safety and Biosafety

whitePaper | November 29, 2019

The Hazard Assessment Programme is concerned with the hazard assessment of industrial chemicals. The current focus of the programme is on the development and application of Integrated Approaches to Testing and Assessment (IATA) and the exchange of experience on new hazard assessment methodologies.

Read More
news image

Decarbonizing practices in the global chemical industry

whitePaper | December 23, 2022

This white paper examines the current state and trajectory of decarbonization within the global chemicals industry. By examining and establishing a baseline on industry action.

Read More
news image

CLIMATE-RELATED MACROECONOMIC RISKS AND OPPORTUNITIES

whitePaper | April 4, 2022

Climate change is generating increased challenges to the environment, public health, and the economy. President Biden has set an ambitious goal for the United States.

Read More
news image

Advanced Recycling Pilot Project

whitePaper | January 24, 2022

The Healthcare Plastics Recycling Council (HPRC) is a private technical coalition of industry peers across the healthcare, recycling, and waste management industries seeking to improve recyclability of plastic products and packaging in healthcare,

Read More
news image

Optimizing Carbon Capture, Utilization and Storage to Meet Ambitious Sustainability Goals

whitePaper | October 5, 2022

The race to a zero carbon future is on. Global oil and gas, petrochemical and chemical companies alike have announced ambitious and broad carbon mitigation.

Read More

Achieving the next frontier of chemicals excellence Digital maturity model to help ease the transition

whitePaper | December 30, 2019

The chemicals industry is going through a transformation. Many existing and emerging trends are shaping the future of the industry, which include increasing competition, a shift in economic power, disruptive innovations in end markets, changes in feedstock, accelerating commoditization, sustainability, digitization, and Industry 4.0. These key developments which are determining the future of chemicals broadly fall into three key themes: ‘Growth and innovation’, ‘Performance and cost optimization’, and ‘Sustainability and circular economy’.

Read More

Chemical Safety and Biosafety

whitePaper | November 29, 2019

The Hazard Assessment Programme is concerned with the hazard assessment of industrial chemicals. The current focus of the programme is on the development and application of Integrated Approaches to Testing and Assessment (IATA) and the exchange of experience on new hazard assessment methodologies.

Read More

Decarbonizing practices in the global chemical industry

whitePaper | December 23, 2022

This white paper examines the current state and trajectory of decarbonization within the global chemicals industry. By examining and establishing a baseline on industry action.

Read More

CLIMATE-RELATED MACROECONOMIC RISKS AND OPPORTUNITIES

whitePaper | April 4, 2022

Climate change is generating increased challenges to the environment, public health, and the economy. President Biden has set an ambitious goal for the United States.

Read More

Advanced Recycling Pilot Project

whitePaper | January 24, 2022

The Healthcare Plastics Recycling Council (HPRC) is a private technical coalition of industry peers
across the healthcare, recycling, and waste management industries seeking to improve recyclability of
plastic products and packaging in healthcare,

Read More

Optimizing Carbon Capture, Utilization and Storage to Meet Ambitious Sustainability Goals

whitePaper | October 5, 2022

The race to a zero carbon future is on. Global oil and gas, petrochemical and chemical companies alike have announced ambitious and broad carbon mitigation.

Read More
More Whitepapers

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

Events